e-learning
resources
European Respiratory Review
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer
El-Chemaly, Souheil and Henske, Elizabeth P.
Source:
Eur Respir Rev 2014; 23: 30-35
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
El-Chemaly, Souheil and Henske, Elizabeth P.. Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer. Eur Respir Rev 2014; 23: 30-35
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lymphangioleiomyomatosis (LAM)
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
The large airway lesions of lymphangioleiomyomatosis: Pathological and radiological analysis
Related content which might interest you:
Questions on the surveillance of COPD: lessons from cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=192
Year: 2005
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Year: 2014
The clinical benefit of personalised medicine in lung cancer
Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms
Year: 2014
Surgery of lung cancer in elderly patients: lessons learned
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008
Bronchiectasis: new therapies and perspectives
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018
PG1 Re-defining the role of chest physicians in lung cancer:ÿnew opportunities in diagnostics and therapy
Source: Milan 2017 - Educational material
Year: 2017
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010
A palliative benefit from chemotherapy - has it impact on symptoms control in the management of metastatic blastoma pulmonum? Case report
Source: Eur Respir J 2002; 20: Suppl. 38, 466s
Year: 2002
Single-institution experience of the combined operations in management of lung cancer: Lessons learned
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003
New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
What is the scientific and clinical rationale? Triple therapy in COPD patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021
CC3 Lung cancer: personalised treatment and palliative care
Source: Paris 2018 - Educational material
Year: 2018
Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019
Endpoints in IPF and lung cancer trials: controversies and perspectives
Source: Research Seminar 2015
Year: 2015
Combination immunotherapy in mesothelioma: managing expectations and new toxicities
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021
Induction chemotherapy before lung cancer resection: experiences and perspectives
Source: Eur Respir J 2004; 24: Suppl. 48, 302s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept